Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9025 Balboa Ave Ste 100, San Diego, Cali...Phone Number
(858) 571-1800Website
www.therapeuticsinc.comRevenue
$25.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1
About Therapeutics
Therapeutics Inc. is a specialized dermatology Contract Research Organization (CRO) that offers integrated, turnkey solutions for drug development, navigating the complexities of non-clinical, clinical, and regulatory processes. With over 20 years of experience, the company is committed to enhancing dermatology drug development through clarity and collaboration. Their comprehensive services include product development, clinical development, and regulatory affairs, tailored to meet the unique needs of their clients. Therapeutics Inc. aims to facilitate seamless communication and workflow to ensure stakeholder satisfaction and successful regulatory approvals.Explore more
Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Therapeutics
Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Therapeutics recently announced quarterly report
Check out if Therapeutics is spiking on competitors!
Click to see if Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Therapeutics launches new products
Funding: Get notified immidiatlly once Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Therapeutics
Compare insights from companies similar to Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$15.5M
51-200
Private
$31M
2003
JH
Jim HavilandVice President, Quality Assurance, Regulatory Compliance & Regulatory Affairs
Company Profile Activity
Activity Insights
Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Therapeutics.
Therapeutics financials insights
Gather financial insights about Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2021
Debt
$1.3M
Therapeutics Tech Stack
A closer look at the technologies used by Therapeutics
Most Recent Scoops
Funding
Project
received an award of $294,948 on August 11, 2023 by HHS NIH with an award end date of July 31, 2024.
Award, Spending/Investment
Funding
Project
Spending/Investment
Funding
Project
Award, Spending/Investment
Open Position
Open Position
Therapeutics News & Media
Remix Therapeutics to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced that management will participate in the following upcoming investor conferences:Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) – BOULDER, Colo., Aug. 24, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage...Galvanize Therapeutics® Announces the Latest Exploratory Evidence Suggesting Immune-Activating Potential of Aliya® PEF Energy
New clinical data published in Clinical Cancer Research , together with independent recognition in Nature Cancer , suggest Aliya PEF may help create an organized immune response within tumors, adding to growing body of evidence that its effects may extend beyond local ablation. REDWOOD...Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides
Platform combines regenerative peptides with autologous platelet-rich biologics, alongside adjunct formulations designed to avoid interfering with the body's own repair cells MEQUON, Wis., Aug. 20, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. ("Vector" or the "Company")...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Therapeutics
Sign Up For FreeTo access detailed company insights
Therapeutics Inc. is a specialized dermatology Contract Research Organization (CRO) that offers integrated, turnkey solutions for drug development, navigating the complexities of non-clinical, clinical, and regulatory processes. With over 20 years of experience, the company is committed to enhancing dermatology drug development through clarity and... Read More
